Pfizer shareholders are collecting a 6% yield while the stock bleeds value, and the CEO just made a bold promise about ...

Pfizer (PFE) has drawn fresh attention after the FDA approved its 2026 to 2027 COMIRNATY XFG COVID-19 vaccine formula for ...

Patient investors who buy the stock may be rewarded over the long term.

Pfizer just marked a fresh 52-week high at $29.02, 1.58% above the peak it set on Aug. 25. Anyone anchored to the low-$23 ...

Pfizer is facing material patent expirations over the next two years, but that will be over by 2030.

Medicus Pharma Ltd. MDCX secured on Wednesday an exclusive, sublicensable global license from Pfizer Inc. PFE to develop, ...

Pfizer (NYSE:PFE) has reached a confidential settlement covering federal lawsuits over its Depo-Provera contraceptive and ...

Pfizer has found a new home for an antibody-drug conjugate it acquired in its $43 billion Seagen buyout and dropped earlier ...

This problem has a solution, and Pfizer is implementing it.

The Food and Drug Administration has approved the latest version of Pfizer and BioNTech's COVID-19 vaccine, the companies ...

Pfizer remains undervalued, demonstrating robust profitability and offering an attractive forward dividend yield above 6%. Read more on PFE stock here.

Pharmaceutical firm Pfizer has turned to Apple Vision Pro to make an experience that's meant to help cancer patients ...